Full Text View
Tabular View
No Study Results Posted
Related Studies
Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa (MSP3-POC)
This study is ongoing, but not recruiting participants.
Study NCT01341704   Information provided by Vac4All

First Received on April 23, 2011.   Last Updated on February 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
MSP3-LSP/AlOH
Verorab Vaccine
0.9% NaCl/Normal Saline
Sponsors listed in this trial
Vac4All
University of Bamako


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services